MAPT and early-onset autosomal dominant Alzheimer disease: Since memory decline is regarded as a harbinger of future global cognitive deterioration in Alzheimer’s disease [28], this means that early increased tau deposit in regions of Braak I/II stages with abnormal amyloid status already can identify the individuals whose cognition starts to deteriorate.